发明名称 |
Kinase inhibitors and methods of use thereof |
摘要 |
Disclosed is 1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(5-fluoro-2-(1-(2-hydroxyethyl)-1H-indazol-5-yloxy)benzyl)urea of formula (I) and compounds of formula (II) and (IV). Also disclosed is the process of making a compound of formula (I), a pharmaceutical composition comprising a compound of formula (I) and the use of a compound of formula (I) or the prodrug 2-(5-(2-((3-(3-tert-butyl-I-p-tolyl-IH-pyrazol-5-yl)ureido )methyl)-4-fluorophenoxy)-1 H-indazol-I-yl)ethyl dihydrogenphosphate in the manufacture of a medicament to treat kinase-mediated conditions particularly inflammatory disease, autoimmune disease, destructive bone disorder, proliferative disorder, infectious disease, viral disease or neurodegenerative disease.
|
申请公布号 |
NZ570846(A) |
申请公布日期 |
2011.08.26 |
申请号 |
NZ20070570846 |
申请日期 |
2007.01.26 |
申请人 |
ARRAY BIOPHARMA, INC. |
发明人 |
GRONEBERG, ROBERT D;WATSON, DANIEL J;BURGESS, LAURENCE E;HARVEY, DARREN;LAIRD, ELLEN;MUNSON, MARK;RIZZI, JAMES;RODRIGUEZ, MARTHA;EARY, CHARLES TODD |
分类号 |
C07D231/40;A61K31/416;A61P29/00;C07D231/56 |
主分类号 |
C07D231/40 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|